Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg); levodopa, quantity: 50 mg - tablet, dispersible - excipient ingredients: magnesium stearate; pregelatinised maize starch; citric acid; microcrystalline cellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, dispersible - excipient ingredients: citric acid; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, uncoated - excipient ingredients: crospovidone; microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; docusate sodium; iron oxide red; calcium hydrogen phosphate; magnesium stearate; ethylcellulose; mannitol - parkinson's disease and parkinsonian symptoms including post- encephalitic and toxic forms, but excluding drug induced parkinsonism.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - capsule, hard - excipient ingredients: indigo carmine; purified talc; gelatin; iron oxide red; magnesium stearate; povidone; microcrystalline cellulose; titanium dioxide - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - levodopa, quantity: 50 mg; benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg) - capsule, hard - excipient ingredients: indigo carmine; iron oxide black; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; povidone; mannitol; gelatin - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

Spanyolország - spanyol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

roche farma, s.a. - levodopa; benserazida hidrocloruro - comprimido - 200 mg/50 mg - levodopa 200 mg; benserazida hidrocloruro 50 mg - levodopa con inhibidor de la descarboxilasa

Spanyolország - spanyol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

roche farma, s.a. - levodopa; benserazida hidrocloruro - cÁpsula dura de liberaciÓn prolongada - 100 mg/25 mg - levodopa 100 mg; benserazida hidrocloruro 25 mg - levodopa con inhibidor de la descarboxilasa

Csehország - cseh - SUKL (Státní ústav pro kontrolu léčiv)

roche s.r.o., praha array - 1645 levodopa; 5580 benserazid-hydrochlorid - tableta - 200mg/50mg - levodopa a inhibitor dekarboxylasy

Szerbia - szerb - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

galenika ad beograd - леводопа, benzerazid - tableta - 200mg+50mg

Szerbia - szerb - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

roche doo beograd - леводопа, benzerazid -